Primary menu

You are here

Challenges in Viral Vector Manufacturing

Thursday, 15th October7:30pm-8:45pm

Nick Page, Chief Operations Officer at Oxford Biomedica, with his 35+ years of industry experience, is ideally placed to tell us about how viruses are used in modern gene and cell therapy. Prior to joining Oxford Biomedica in April 2018, he has held a number of senior operational leadership positions in the pharmaceutical industry, most recently as Platform Head of Anti-infectives within Novartis. His industry experience includes API, Solid oral dose, Sterile, and Radiopharmaceutical manufacturing in various organisations encompassing innovative, generic and contract manufacturing. During his career he has spent several years working in China and India as well as in Global roles. He originally qualified as a Chartered Chemist and also has an MBA from The Open University.

Print Friendly, PDF & Email
Click map for full detail
Back to Top